David Israeli

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Samsara Vision, Inc. engages in the business of research, development, manufacturing, and marketing proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. It operates under the United States and Other geographical segments. The company was founded by Isaac Lipshitz, David Lifschitz, Yossi Gross, Boaz Lifschitz, and Eyal Lifschitz in 1997 and is headquartered in Far Hills, NJ.

Rhythmia Medical, Inc. was a venture-backed medical device company focused on advanced treatment of arrhythmia. It focused on developing a next generation Mapping, Visualization and Navigation system for the treatment of cardiac arrhythmias. The company was founded in 2004 and was headquartered in Burlington, MA.

Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel.

APOS Medical Israel Ltd. is a holding company that provides non-surgical medical treatment services for musculoskeletal disorders. It offers AposTherapy, a non-surgical and drug-free medical program for knee and back pain, which utilizes an individually calibrated, foot-worn biomechanical device. The firm's program treats body's mal-alignment, muscle weakness, impaired neuromuscular control, and the resulted abnormal pathological movement patterns of orthopaedic conditions. The company was founded by Avi Elbaz and Amit Mor in 2004 and is headquartered in Herzliya Pituach, Israel.

Magenta Medical Ltd. develops medical devices for the treatment of acute and congestive heart failure. It offers a temporary venous catheter-based therapy for hospital-admitted patients. The firm?s novel therapeutic principle is aimed at addressing renal venous congestion and its deleterious effects on renal and cardiac function that is a pathophysiological core element of acute heart failure. The company was founded by Ehud Schwammenthal and Yosi Tuval in October 2012 and is headquartered in Kadima, Israel.

keepMED Ltd. manufactures innovative devices for treating obstructive sleep apnea. It offers keePAP, a wearable device that comprises of a lightweight unobtrusive nasal interface and a miniature battery-operated control unit that is used for the treatment of obstructive sleep apnea. The company was founded by Rapoport Alex and is headquartered in Rishon Le Zion, Israel.